Alpha-fetoprotein (AFP) is a well-known biomarker for hepatocellular carcinoma, but a problem is that serum AFP levels are increased in patients with liver cirrhosis and chronic hepatitis [5]. The gene discussed is AFP; the disease is hepatocellular carcinoma.